Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Collagen Corp. and ABC's 20/20

This article was originally published in The Gray Sheet

Executive Summary

At a March 30 session of the HIMA annual meeting, John Stossel, reporter for the ABC television program 20/20, said he will consider doing a story that provides data from studies indicating that use of Collagen's Zyderm/Zyplast injectable collagen products is not associated with autoimmune disease. A Stossel report on the Feb. 22, 1991 broadcast of 20/20 highlighted claims from individuals who believe that Collagen's products have caused autoimmune disorders ("The Gray Sheet" March 4, 1991, p. 6). Noting that plaintiffs attorneys told him that use of Collagen's products "would lead to all kinds of autoimmune disease," Stossel told the HIMA gathering that "given that the product is in a lot of places, you would think [autoimmune disease] would start showing up all over, and so far it hasn't. And if that continues down the road, and collagen is widely accepted, then I think...I should do a followup story" on how "the emphasis of our story was wrong".

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel